Fipronil 9.8%/S-Methoprene 8.8%/Cyphenothrin 5.2% Squeeze-On

Verify with FDA CVM →

556 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
556
Total Reports
2
Deaths Reported
40.0%
Death Rate

Active Ingredients

Fipronil 9.8%/S-Methoprene 8.8%/Cyphenothrin 5.2% Squeeze-On

Administration Routes

UnknownOtherOralSubconjunctivalTopical

Species Affected

Dog 556

Most Affected Breeds

Shih Tzu 78
Crossbred Canine/dog 42
Bichon Frise 39
Maltese 38
Retriever - Labrador 24
Chihuahua 23
Poodle - Toy 20
Retriever - Golden 19
Terrier - Yorkshire 18
Spitz - German Pomeranian 15

Most Reported Reactions

Restlessness 139
Behavioural disorder NOS 79
Hyperactivity 71
Itching 68
Scratching 68
Twitching 60
Lethargy (see also Central nervous system depression in 'Neurological') 53
Vomiting 52
Agitation 45
Vocalisation 39
Anxiety 39
Panting 38

Outcome Breakdown

Recovered/Normal
271 (48.7%)
Outcome Unknown
266 (47.8%)
Ongoing
16 (2.9%)
Euthanized
1 (0.2%)
Recovered with Sequela
1 (0.2%)
Died
1 (0.2%)

Data Summary

Metric Value
Total adverse event reports 556
Reports involving death 2
Case-fatality rate (reported events) 40.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Fipronil 9.8%/S-Methoprene 8.8%/Cyphenothrin 5.2% Squeeze-On Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 556 adverse event reports referencing Fipronil 9.8%/S-Methoprene 8.8%/Cyphenothrin 5.2% Squeeze-On, including 2 reports in which the animal died — a 40.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Fipronil 9.8%/S-Methoprene 8.8%/Cyphenothrin 5.2% Squeeze-On. Reported administration routes include Unknown, Other, Oral, Subconjunctival. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Fipronil 9.8%/S-Methoprene 8.8%/Cyphenothrin 5.2% Squeeze-On reports are Dog (556 reports), with Dog accounting for the largest share. Within those species, Shih Tzu (78), Crossbred Canine/dog (42), Bichon Frise (39) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Fipronil 9.8%/S-Methoprene 8.8%/Cyphenothrin 5.2% Squeeze-On are Restlessness (139), Behavioural disorder NOS (79), Hyperactivity (71), Itching (68). Of the 556 reports with a coded outcome, Recovered/Normal is the leading category at 48.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Fipronil 9.8%/S-Methoprene 8.8%/Cyphenothrin 5.2% Squeeze-On.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial